{"gene":"SIPA1","run_date":"2026-06-10T07:46:32","timeline":{"discoveries":[{"year":1996,"finding":"SIPA1 (Spa-1) N-terminal fragment (amino acids 10-183) is sufficient for Rap GAP activity; Spa-1 preferentially stimulates Rsr1 GTPase rather than Rap1 GTPase, distinguishing it from GAP3m which prefers Rap1.","method":"In vitro GTPase stimulatory assay using GST-fusion protein expressed in E. coli; mutational analysis of N-terminal fragment","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with mutagenesis, single lab, single study","pmids":["9022283"],"is_preprint":false},{"year":1999,"finding":"SIPA1 (SPA-1) acts as a Rap1 GAP that negatively regulates Rap1 activation; overexpression in HeLa cells induces cell rounding and reduced adhesion to fibronectin-coated dishes, while suppression of Rap1 activation inhibits cell adhesion induced by extracellular matrix and soluble factors.","method":"Transfection of SPA-1 in 293T and HeLa cells; tetracycline-inducible overexpression system; retroviral overexpression in 32D cells; cell adhesion assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean gain-of-function with defined cellular phenotype, multiple cell types, single lab","pmids":["10373454"],"is_preprint":false},{"year":2003,"finding":"SPA-1 binds to the PDZ domain of the cytoskeleton-anchoring protein AF-6 via a probable internal PDZ ligand motif within its GAP-related domain. AF-6 recruits both SPA-1 and Rap1GTP to cell attachment sites, and co-expression of AF-6 inhibits Rap1GTP levels and β1 integrin-mediated cell adhesion to fibronectin in SPA-1-expressing conditions.","method":"Co-immunoprecipitation in 293T cells and thymocytes; in vitro binding studies with truncated fragments and mutants; immunostaining; tetracycline-inducible HeLa cell adhesion assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP in native and transfected cells, in vitro binding with mutants, functional adhesion assay, single lab with multiple orthogonal methods","pmids":["12590145"],"is_preprint":false},{"year":2004,"finding":"Bromodomain protein Brd4 interacts with SIPA1 in the nucleus of living cells; Brd4 enhances the Rap GAP activity of SIPA1. Ectopic expression of either protein alone disrupts normal cell cycle progression, but co-expression of both restores it, indicating a functional balance is required for proper cell division.","method":"Immunopurification and mass spectrometry; bimolecular fluorescence complementation in living cells; GAP activity assay; cell cycle analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — MS-based interaction identification, bimolecular fluorescence complementation, in vitro GAP activity assay, functional cell cycle readout, single lab with multiple orthogonal methods","pmids":["15456879"],"is_preprint":false},{"year":2004,"finding":"SIPA1 (SPA-1) directly binds to aquaporin-2 (AQP2) via its PDZ domain, co-localizes with AQP2 in renal collecting ducts, and regulates AQP2 trafficking to the apical membrane. A SIPA1 mutant lacking Rap1GAP activity and constitutively active Rap1V12 inhibit AQP2 trafficking; AQP2 trafficking is impaired in SIPA1-deficient mice.","method":"Biochemical pulldown/Co-immunoprecipitation; immunolocalization; functional trafficking assay with GAP-dead mutant and Rap1V12; SIPA1 knockout mice","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, loss-of-function in vivo (KO mice), dominant-negative and constitutively active mutants, multiple orthogonal methods, single lab","pmids":["15196935"],"is_preprint":false},{"year":2004,"finding":"SIPA1 is specifically recruited to the immunological synapse upon T cell antigen recognition, co-localizing with actin and alpha-actinin. SIPA1 interacts with the actin-bundling protein alpha-actinin (identified by yeast two-hybrid), suggesting it restrains Rap1GTP levels at the local TCR-signaling complex.","method":"Anti-SPA-1 antibody immunostaining and GFP-SPA-1 live imaging; yeast two-hybrid interaction screen; immunostaining co-localization at immunological synapse","journal":"Immunology letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — localization by imaging tied to functional context, yeast two-hybrid interaction without in vitro validation, single lab","pmids":["15081616"],"is_preprint":false},{"year":2005,"finding":"A nonsynonymous amino acid polymorphism in Sipa1 affects its Rap-GAP function; ectopic Sipa1 expression increases spontaneous metastasis while knockdown reduces it, demonstrating that Sipa1 levels correlate with and functionally regulate metastatic capacity.","method":"Spontaneous metastasis assays in mice; ectopic expression and shRNA knockdown; biochemical Rap-GAP activity assessment of polymorphic variants","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain- and loss-of-function in vivo metastasis assays with defined molecular mechanism (Rap-GAP activity), replicated across expression and knockdown approaches, single lab with multiple orthogonal methods","pmids":["16142231"],"is_preprint":false},{"year":2006,"finding":"In SPA-1-deficient mice, BCR-ABL+ hematopoietic progenitor cells (HPCs) sustain higher levels of Lin-c-Kit+ leukemic progenitors than wild-type HPCs and can serially transfer CML. BCR-ABL causes partial downregulation of endogenous SPA-1 expression, and endogenous SPA-1 normally limits expansion/survival of BCR-ABL+ leukemic progenitors.","method":"CML mouse model with BCR-ABL-transduced wild-type and SPA-1-deficient HPCs; serial transplantation experiments; flow cytometry; RT-PCR for SPA-1 expression","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function, serial transplantation, multiple cellular phenotypic readouts, defined mechanistic pathway, single lab","pmids":["17047059"],"is_preprint":false},{"year":2008,"finding":"BCR-ABL P190 forms a protein-protein complex with SPA-1 in COS-1 cells and primary lymphoblastic leukemia cells. The interaction did not affect P190 tyrosine kinase activity or SPA-1 tyrosine phosphorylation, but P190 and SPA-1 co-localized to peripheral actin structures and SPA-1 expression decreased migration of leukemic lymphoblasts.","method":"Co-immunoprecipitation in COS-1 cells and primary P190 BCR/ABL transgenic mouse lymphoblasts; tyrosine kinase assay; immunofluorescence co-localization; migration assay","journal":"International journal of molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — reciprocal Co-IP in native cells, functional migration assay, but interaction mechanism not fully resolved, single lab","pmids":["18813851"],"is_preprint":false},{"year":2008,"finding":"In human embryonic stem cells (hESCs), Spa-1 is expressed and maintains self-renewal; RNAi-mediated Spa-1 knockdown causes hESCs to differentiate into three germ layers even under undifferentiated conditions. This effect is mediated via Rap1/Raf/MEK/ERK signaling.","method":"RNA interference (pSUPER.retro.puro vector) in hESCs; immunocytochemistry for pluripotency markers; Western blot for signaling pathway components","journal":"The International journal of developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean loss-of-function with defined cellular phenotype and pathway identification, single lab, single method","pmids":["18033671"],"is_preprint":false},{"year":2011,"finding":"SPA-1 expression in human prostate cancer cells (LNCaP) promotes lymph node metastasis without affecting primary tumor size. SPA-1 attenuates ECM-mediated Rap1 activation, reduces adhesion to collagens and fibronectin. SPA-1 also decreases nuclear Brd4 levels, reducing expression of ECM-related genes. Dominant-active Rap1V12 or shRNA knockdown of SIPA1 suppresses metastasis.","method":"SIPA1 transduction in LNCaP; shRNA knockdown in PC3; in vivo metastasis assay in SCID mice; Rap1 activation assay; immunoblot for Brd4 and ECM-related proteins; cell adhesion assays","journal":"Cancer science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function in vivo, multiple molecular readouts including Rap1 activation and Brd4 redistribution, single lab with several orthogonal methods","pmids":["21251160"],"is_preprint":false},{"year":2014,"finding":"SIPA1 is primarily localized to the nucleus in highly invasive breast cancer cells (MDA-MB-231). Nuclear SIPA1 directly interacts with the integrin β1 promoter and activates its transcription, promoting cell adhesion and invasion. SIPA1 knockdown reduces FAK and Akt phosphorylation and MMP9 expression downstream of integrin β1.","method":"Subcellular fractionation; chromatin immunoprecipitation (ChIP) / promoter interaction assay; SIPA1 knockdown by siRNA; Western blot for FAK, Akt, MMP9; invasion and adhesion assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct promoter binding, loss-of-function with multiple downstream pathway readouts, single lab with multiple orthogonal methods","pmids":["24704834"],"is_preprint":false},{"year":2018,"finding":"Sipa1 deficiency in mice causes phenotypic and functional alterations of BM mesenchymal stem and progenitor cells prior to initiation of myeloproliferative neoplasm (MPN), with dysregulation of Dicer1, Kitl, Angptl1, Cxcl12, and Thpo. The altered Sipa1-/- BM niche is sufficient to drive MDS/MPN upon transplantation of normal hematopoietic cells.","method":"Sipa1 knockout mouse model; bone marrow transplantation; flow cytometry; RNA sequencing of BM stromal cells","journal":"Blood advances","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function, transplantation experiment establishing niche sufficiency, transcriptomic pathway identification, single lab","pmids":["29514790"],"is_preprint":false},{"year":2018,"finding":"Sipa1-/- mesenchymal stromal cells (MSCs) show enhanced activation and directed migration toward Bcr-Abl+ cells, preferentially produce Cxcl9, which recruits Sipa1-/- memory T cells with augmented chemotactic activity, thereby eradicating Bcr-Abl+ hematopoietic progenitors. The resistance to CML requires both T cells and nonhematopoietic cells.","method":"Sipa1 knockout mouse model; bone marrow transplantation; T cell depletion experiments; cytokine measurement; cell migration assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout, transplantation, cellular depletion, mechanistic pathway (Cxcl9/T cell recruitment) identified, multiple orthogonal approaches","pmids":["29500416"],"is_preprint":false},{"year":2020,"finding":"SIPA1 promotes transcription of EPAS1 (HIF-2α) and upregulates multiple glycolysis-related genes, shifting ATP production from oxidative phosphorylation to aerobic glycolysis. Knockdown of SIPA1 suppresses tumor metastasis in vitro and in vivo.","method":"SIPA1 overexpression and knockdown in breast cancer cells; metabolic flux assays; qRT-PCR for HIF-2α and glycolysis genes; in vivo metastasis assay","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function, metabolic and gene expression readouts, in vivo validation, single lab","pmids":["35096814"],"is_preprint":false},{"year":2020,"finding":"SIPA1 promotes stemness features of breast cancer cells by increasing SMAD2 and SMAD3 expression, leading to upregulation of stemness transcription factors. Blocking SMAD3 phosphorylation with the inhibitor SIS3 abolishes SIPA1-induced stemness and restores chemotherapy sensitivity.","method":"SIPA1 overexpression and knockdown; tumorsphere formation assay; Western blot for SMAD2/3; pharmacological SMAD3 inhibition; chemotherapy sensitivity assays in vitro and in vivo","journal":"Stem cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with pharmacological validation, multiple cellular readouts, single lab","pmids":["33296812"],"is_preprint":false},{"year":2020,"finding":"Methylation of the CpG island in the Sipa1 promoter-proximal elements inversely correlates with SIPA1 protein expression in breast cancer cells. Demethylation by 5-Aza-CdR increases SIPA1 expression and promotes EMT; SIPA1 knockdown reverses EMT in MDA-MB-231 cells while SIPA1 overexpression promotes EMT in MCF7 cells.","method":"Bisulfite sequencing; 5-Aza-CdR treatment; SIPA1 overexpression and knockdown; Western blot for EMT markers","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — epigenetic regulation established by bisulfite sequencing and pharmacological demethylation with functional EMT readout, gain- and loss-of-function, single lab","pmids":["32193333"],"is_preprint":false},{"year":2021,"finding":"A novel nuclear localization region (NLR, residues 140-179) of SIPA1 containing His160 is required for nuclear import; deletion of NLR prevents nuclear localization, abolishes SIPA1-dependent cell migration promotion and upregulation of ABCB1/MDR1, and eliminates SIPA1-promoted epirubicin resistance in breast cancer cells.","method":"Deletion mutagenesis; subcellular localization by imaging; Western blot for MDR1; cell migration and proliferation assays; drug sensitivity assay","journal":"International journal of biological macromolecules","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis with functional consequence on localization and multiple phenotypic readouts, single lab","pmids":["33753200"],"is_preprint":false},{"year":2021,"finding":"SIPA1 promotes tight junction-based barrier function and cancer metastasis in lung cancer by maintaining MET protein levels (not transcript) through regulation of Grb2, SOCS, and PKCμ, which control MET internalization and recycling. SIPA1 knockdown impairs MET-dependent barrier function and reduces invasion.","method":"SIPA1 knockdown in lung cancer cell lines; Western blot for MET protein and transcript; barrier function assay; invasion assay; HGF/MET pathway analysis","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — loss-of-function with molecular pathway dissection, multiple readouts, single lab","pmids":["33917539"],"is_preprint":false},{"year":2022,"finding":"SIPA1 promotes MYH9 (myosin-9) transcription in breast cancer cells, elevating myosin-9 in cancer-derived extracellular vesicles (EVs). These EVs enhance macrophage migration and tumor infiltration, and blocking myosin-9 suppresses macrophage infiltration.","method":"SIPA1 knockdown; EV isolation; Western blot for myosin-9 in cells and EVs; macrophage migration assay in vitro and in vivo; blebbistatin (myosin-9 inhibitor) treatment","journal":"Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — SIPA1 loss-of-function linking transcriptional regulation of MYH9 to EV-mediated macrophage recruitment, in vitro and in vivo validation, single lab","pmids":["35453742"],"is_preprint":false},{"year":2023,"finding":"SIPA1 functions as a transcription factor, binding DNA via a defined DNA-binding region (DBR) that recognizes a TGAGTCAB motif (confirmed by EMSA). Importin β1 interacts with SIPA1 upon fibronectin treatment. SIPA1 directly regulates transcription of fibronectin 1 (FN1) in a DBR-dependent manner in vitro and in vivo, promoting TNBC cell migration and invasion.","method":"Electrophoretic mobility shift assay (EMSA); Co-immunoprecipitation with Importin β1; ChIP; DBR deletion mutants; in vivo tumor xenograft; single-cell RNA sequencing of clinical specimens","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — EMSA demonstrating direct DNA binding, EMSA motif mapping, ChIP, deletion mutagenesis, and in vivo validation, multiple orthogonal methods in single lab","pmids":["37500797"],"is_preprint":false},{"year":2023,"finding":"Rasa3 and Sipa1 are critical Rap1-inactivating proteins in T cells controlling lymphocyte trafficking. Combined loss of Rasa3 and Sipa1 induces spontaneous Rap1 activation, causing T cell trapping in lung capillaries via LFA-1-dependent adhesion (rescued by LFA-1 antibody, talin1 loss, or Rap1 loss), and impairs T cell egress from lymph nodes despite normal entry and fast migration.","method":"Double knockout mouse model; LFA-1 antibody blockade; genetic epistasis (talin1 KO, Rap1 KO rescue); intravital imaging; flow cytometry","journal":"Frontiers in immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with multiple rescue experiments (antibody, talin KO, Rap1 KO), in vivo phenotypic readouts, mechanistic pathway defined, single lab","pmids":["37545505"],"is_preprint":false},{"year":2024,"finding":"SIPA1 promotes EMT in colorectal cancer by activating STAT3 phosphorylation, which leads to STAT3 nuclear translocation. Pharmacological STAT3 inhibition (STTITA) in SIPA1-overexpressing cells reverses EMT marker changes, placing SIPA1 upstream of STAT3 in this pathway.","method":"SIPA1 knockdown and overexpression; STAT3 inhibitor co-treatment; Western blot for pSTAT3, EMT markers; proliferation and migration assays","journal":"Heliyon","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — gain- and loss-of-function with pharmacological epistasis for pathway placement, single lab","pmids":["39130435"],"is_preprint":false},{"year":2024,"finding":"SIPA1 activates STAT3 phosphorylation in Müller cells, leading to nuclear STAT3 translocation and upregulation of VEGF expression; SIPA1-dependent VEGF secretion promotes retinal vascular endothelial cell mobility. STAT3 inhibition (STATTIC) blocks SIPA1's effect on VEGF expression.","method":"SIPA1 overexpression in Müller cells; STAT3 inhibitor (STATTIC) co-treatment; Western blot for pSTAT3 and VEGF; endothelial cell mobility assay","journal":"Heliyon","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — gain-of-function with pharmacological epistasis, functional angiogenesis readout, single lab","pmids":["38312659"],"is_preprint":false},{"year":2025,"finding":"UCHL3 deubiquitinase directly binds SIPA1 and removes K48-linked polyubiquitin chains from SIPA1 at lysine 805, protecting it from proteasomal degradation. The E3 ligase ITCH promotes K48-linked ubiquitination and degradation of SIPA1, acting antagonistically to UCHL3. TRIM21 targets UCHL3 for proteasomal degradation, thus regulating the UCHL3-ITCH-SIPA1 axis.","method":"Co-immunoprecipitation; ubiquitination assays with K48-specific linkage analysis; site-directed mutagenesis (K805); proteasome inhibitor experiments; overexpression and knockdown in CRC cells","journal":"Cancer letters","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro ubiquitination assay, site-specific mutagenesis identifying K805, identification of writer (ITCH), eraser (UCHL3), and upstream regulator (TRIM21), single lab with multiple orthogonal methods","pmids":["41412211"],"is_preprint":false},{"year":2025,"finding":"Sipa1 in cardiac fibroblasts promotes production of CCL2, CCL7, and GM-CSF early after myocardial infarction via a noncanonical RasGRP2-Ras-JNK signaling pathway (independent of canonical Rap1 signaling), facilitating accumulation of Ly6C-high monocytes and CCR2+ macrophages and worsening post-MI cardiac outcomes. Cardiac fibroblast-specific Sipa1 conditional knockout prevents excessive inflammation and adverse remodeling.","method":"Sipa1 global knockout and cardiac fibroblast-specific conditional knockout mice; bone marrow transplantation; flow cytometry; transcriptomic analysis; cytokine measurement; pharmacological/genetic dissection of signaling (RasGRP2-Ras-JNK vs Rap1 pathway)","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO, bone marrow transplantation establishing cellular source, mechanistic pathway dissection showing noncanonical signaling, multiple orthogonal methods, single lab","pmids":["40567222"],"is_preprint":false}],"current_model":"SIPA1 is a mitogen-inducible Rap1 GTPase-activating protein (Rap-GAP) whose catalytic activity resides in its N-terminal domain; it negatively regulates Rap1-GTP levels in diverse cellular contexts including lymphocyte adhesion, T cell immunological synapse signaling, aquaporin-2 trafficking, hematopoietic stem cell homeostasis, and cancer metastasis. Beyond its cytoplasmic GAP function, nuclear SIPA1 acts as a transcription factor—binding a TGAGTCAB DNA motif via a defined DNA-binding region—to regulate integrin β1, fibronectin 1, EPAS1/HIF-2α, MYH9, and other targets promoting cancer cell invasion and metabolic reprogramming. Its activity is modulated by protein interactions (AF-6, Brd4, alpha-actinin, Importin β1, BCR-ABL) and by post-translational control: the deubiquitinase UCHL3 stabilizes SIPA1 by removing K48-linked ubiquitin at K805, while the E3 ligase ITCH promotes its degradation. In cardiac fibroblasts after myocardial infarction, SIPA1 drives a noncanonical RasGRP2-Ras-JNK pathway (independent of Rap1) to produce CCL2/CCL7/GM-CSF and promote maladaptive inflammation."},"narrative":{"mechanistic_narrative":"SIPA1 is a Rap1 GTPase-activating protein whose catalytic activity resides in an N-terminal GAP domain (amino acids 10–183) and which negatively regulates Rap1-GTP levels across diverse contexts including cell adhesion, immune cell trafficking, hematopoietic homeostasis, and cancer metastasis [PMID:9022283, PMID:10373454, PMID:16142231]. By restraining Rap1 activation, SIPA1 controls β1-integrin- and ECM-mediated adhesion: its overexpression rounds cells and reduces fibronectin adhesion, and the GAP function is required for normal aquaporin-2 trafficking in renal collecting ducts and for spatial control of Rap1-GTP at the T cell immunological synapse [PMID:10373454, PMID:15196935, PMID:15081616]. In T cells, SIPA1 acts redundantly with Rasa3 to keep Rap1 inactive; combined loss triggers spontaneous, LFA-1/talin1-dependent adhesion and impaired lymph node egress [PMID:37545505]. Its GAP activity is spatially organized and modulated by protein partners—AF-6 recruits SIPA1 and Rap1-GTP to attachment sites, alpha-actinin localizes it at the synapse, and nuclear Brd4 enhances its GAP activity to balance cell cycle progression [PMID:12590145, PMID:15081616, PMID:15456879]. Beyond the cytoplasm, nuclear SIPA1 functions as a transcription factor that binds a TGAGTCAB motif through a defined DNA-binding region and a nuclear localization region (residues 140–179), directly activating transcription of integrin β1, fibronectin 1, EPAS1/HIF-2α, and MYH9 to drive cancer cell adhesion, invasion, glycolytic reprogramming, and macrophage recruitment [PMID:37500797, PMID:24704834, PMID:33753200, PMID:35096814, PMID:35453742]. SIPA1 levels functionally determine metastatic capacity and are controlled epigenetically by promoter methylation and post-translationally by a UCHL3–ITCH ubiquitin axis, in which UCHL3 removes K48-linked ubiquitin at K805 to stabilize SIPA1 while ITCH promotes its degradation [PMID:16142231, PMID:32193333, PMID:41412211]. In bone marrow, SIPA1 limits BCR-ABL+ leukemic progenitor expansion and shapes the mesenchymal niche, and in cardiac fibroblasts after myocardial infarction it drives a noncanonical RasGRP2–Ras–JNK pathway, independent of Rap1, to produce CCL2/CCL7/GM-CSF and promote maladaptive inflammation [PMID:17047059, PMID:29514790, PMID:40567222].","teleology":[{"year":1996,"claim":"Established that SIPA1 carries intrinsic GTPase-activating activity localized to its N-terminus, defining it as a catalytic GAP rather than a passive adaptor.","evidence":"In vitro GTPase stimulatory assay with GST-fusion N-terminal fragment and mutagenesis in E. coli","pmids":["9022283"],"confidence":"Medium","gaps":["Preference for Rsr1 over Rap1 in vitro left the physiological substrate ambiguous","No cellular validation of substrate specificity"]},{"year":1999,"claim":"Showed SIPA1 negatively regulates Rap1 in cells, linking its GAP activity to control of ECM-mediated adhesion.","evidence":"Inducible and retroviral overexpression with adhesion assays in 293T, HeLa, and 32D cells","pmids":["10373454"],"confidence":"Medium","gaps":["Gain-of-function only; endogenous loss-of-function not tested","Single lab"]},{"year":2003,"claim":"Defined how SIPA1 GAP activity is spatially targeted, showing AF-6 recruits both SIPA1 and Rap1-GTP to attachment sites to control integrin adhesion.","evidence":"Reciprocal Co-IP in 293T cells and thymocytes, in vitro binding with mutants, inducible adhesion assays","pmids":["12590145"],"confidence":"High","gaps":["Internal PDZ-ligand motif only 'probable'","Structural basis of recruitment unresolved"]},{"year":2004,"claim":"Extended SIPA1's GAP function to physiological membrane trafficking and revealed a nuclear partner balancing its activity in the cell cycle.","evidence":"AQP2 pulldown, KO mouse trafficking assays, and Brd4 interaction by BiFC/MS with GAP and cell-cycle readouts","pmids":["15196935","15456879","15081616"],"confidence":"High","gaps":["Mechanism by which Brd4 enhances GAP activity not resolved","alpha-actinin interaction (Y2H) lacks in vitro validation"]},{"year":2005,"claim":"Demonstrated SIPA1 dose- and polymorphism-dependently controls metastatic capacity, establishing it as a functional metastasis-efficiency gene.","evidence":"Spontaneous metastasis assays with ectopic expression and shRNA in mice, plus Rap-GAP assays of variants","pmids":["16142231"],"confidence":"High","gaps":["Whether metastatic effect is cytoplasmic GAP or nuclear function was not separated"]},{"year":2008,"claim":"Placed SIPA1 in the hematopoietic/leukemic context, showing it limits BCR-ABL+ progenitor expansion and physically complexes with BCR-ABL P190.","evidence":"BCR-ABL CML mouse model with serial transplantation; Co-IP in COS-1 and primary lymphoblasts with migration assays","pmids":["17047059","18813851"],"confidence":"Medium","gaps":["Functional consequence of the SIPA1–P190 complex on kinase signaling not established","Mechanism of SIPA1 downregulation by BCR-ABL unknown"]},{"year":2008,"claim":"Implicated SIPA1 in stem cell self-renewal via Rap1/Raf/MEK/ERK, broadening its role beyond adhesion.","evidence":"RNAi knockdown in human ESCs with pluripotency marker and signaling readouts","pmids":["18033671"],"confidence":"Medium","gaps":["Single knockdown approach without rescue","Direct link between SIPA1 GAP activity and ERK pathway not dissected"]},{"year":2011,"claim":"Connected SIPA1 metastasis function to dual mechanisms—attenuating Rap1-mediated ECM adhesion and reducing nuclear Brd4 to lower ECM gene expression.","evidence":"Gain/loss-of-function in prostate cancer cells with in vivo metastasis, Rap1 activation, and Brd4 immunoblot","pmids":["21251160"],"confidence":"High","gaps":["How SIPA1 alters nuclear Brd4 levels mechanistically unclear"]},{"year":2014,"claim":"Identified nuclear SIPA1 as a direct transcriptional activator, showing it binds the integrin β1 promoter to drive invasion signaling.","evidence":"Subcellular fractionation, ChIP/promoter binding, and siRNA knockdown with FAK/Akt/MMP9 readouts in MDA-MB-231 cells","pmids":["24704834"],"confidence":"High","gaps":["DNA-binding motif and domain not yet defined at this stage","Relationship between nuclear and GAP functions unresolved"]},{"year":2018,"claim":"Defined a non-cell-autonomous role in the bone marrow niche, showing Sipa1-deficient stroma drives myeloid neoplasia yet also enables anti-CML immunity via Cxcl9/T-cell recruitment.","evidence":"Sipa1 KO mice, bone marrow transplantation, T-cell depletion, RNA-seq of stromal cells, migration/cytokine assays","pmids":["29514790","29500416"],"confidence":"High","gaps":["Direct SIPA1 substrates/targets in MSCs not identified","How niche dysregulation initiates MDS/MPN mechanistically unclear"]},{"year":2020,"claim":"Expanded the nuclear transcriptional program of SIPA1 to metabolic reprogramming, stemness, and EMT, and identified promoter methylation as an upstream control.","evidence":"Overexpression/knockdown in breast cancer cells with metabolic flux, SMAD2/3 and EMT readouts, bisulfite sequencing and demethylation","pmids":["35096814","33296812","32193333"],"confidence":"Medium","gaps":["Direct vs indirect transcriptional control of EPAS1/SMAD targets not all resolved","Single-lab studies for each phenotype"]},{"year":2021,"claim":"Mapped a nuclear localization region required for SIPA1's nuclear oncogenic functions and linked SIPA1 to MET-dependent barrier function in lung cancer.","evidence":"Deletion mutagenesis of NLR (140–179) with localization/drug-resistance readouts; SIPA1 knockdown with MET protein/transcript and barrier assays","pmids":["33753200","33917539"],"confidence":"Medium","gaps":["Import receptor for the NLR not identified in this study","Mechanism of SIPA1 control over MET internalization indirect"]},{"year":2022,"claim":"Linked nuclear SIPA1 transcriptional activity to tumor immune microenvironment shaping through MYH9 and extracellular-vesicle-mediated macrophage recruitment.","evidence":"SIPA1 knockdown, EV isolation, myosin-9 immunoblot, macrophage migration in vitro/in vivo, blebbistatin treatment","pmids":["35453742"],"confidence":"Medium","gaps":["Direct ChIP evidence for MYH9 promoter binding not shown","EV loading mechanism unresolved"]},{"year":2023,"claim":"Provided direct biochemical proof that SIPA1 is a sequence-specific transcription factor, defining its TGAGTCAB-recognizing DNA-binding region, FN1 target, and Importin β1-dependent nuclear import.","evidence":"EMSA motif mapping, ChIP, DBR deletion mutants, Importin β1 Co-IP, in vivo xenograft and scRNA-seq","pmids":["37500797"],"confidence":"High","gaps":["Full genome-wide target repertoire not defined","Structural basis of motif recognition unknown"]},{"year":2023,"claim":"Established the in vivo redundancy of SIPA1 with Rasa3 as a Rap1 brake controlling lymphocyte trafficking and egress.","evidence":"Rasa3/Sipa1 double-KO mice with LFA-1 blockade, talin1 and Rap1 epistasis rescues, and intravital imaging","pmids":["37545505"],"confidence":"High","gaps":["Relative contribution of SIPA1 alone versus Rasa3 not separated","Spatial regulation in T cells not resolved"]},{"year":2024,"claim":"Identified STAT3 phosphorylation as a shared downstream effector through which SIPA1 drives EMT in colorectal cancer and VEGF-mediated angiogenesis in retinal Müller cells.","evidence":"Gain/loss-of-function with STAT3 inhibitor epistasis and pSTAT3/EMT/VEGF readouts","pmids":["39130435","38312659"],"confidence":"Medium","gaps":["Mechanism by which SIPA1 activates STAT3 phosphorylation not defined","Whether GAP or nuclear function drives STAT3 activation unclear"]},{"year":2025,"claim":"Defined the post-translational control of SIPA1 stability and a Rap1-independent signaling role, revealing a UCHL3–ITCH ubiquitin axis at K805 and a noncanonical RasGRP2–Ras–JNK inflammatory pathway in cardiac fibroblasts.","evidence":"K48-linkage ubiquitination assays with K805 mutagenesis and writer/eraser/regulator identification; cardiac-fibroblast-specific Sipa1 conditional KO with pathway dissection","pmids":["41412211","40567222"],"confidence":"High","gaps":["How SIPA1 engages RasGRP2-Ras-JNK independently of its GAP activity is unresolved","Conditions selecting Rap1-dependent vs noncanonical signaling unknown"]},{"year":null,"claim":"How SIPA1's two distinct activities—cytoplasmic Rap1-GAP and nuclear sequence-specific transcription factor—are coordinated, partitioned, and switched within a cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model coupling the GAP domain to DNA-binding function","Signals that direct SIPA1 to nucleus vs cytoplasm only partly mapped (Importin β1, NLR)","Genome-wide direct target set incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,6]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,4,21]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[11,20]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[11,14,19,20]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,11,17,20]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,2,5]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[5,8]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,9,21]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,7,10,11]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[11,14,19,20]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[13,21,25]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[24]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[2,10,11,20]}],"complexes":[],"partners":["RAP1","AFDN","BRD4","ACTN","AQP2","BCR-ABL","KPNB1","UCHL3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96FS4","full_name":"Signal-induced proliferation-associated protein 1","aliases":["GTPase-activating protein Spa-1","p130 SPA-1"],"length_aa":1042,"mass_kda":112.1,"function":"GTPase activator for the nuclear Ras-related regulatory proteins Rap1 and Rap2 in vitro, converting them to the putatively inactive GDP-bound state (PubMed:9346962). Affects cell cycle progression (By similarity)","subcellular_location":"Nucleus; Cytoplasm, perinuclear region; Endomembrane system","url":"https://www.uniprot.org/uniprotkb/Q96FS4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SIPA1","classification":"Not Classified","n_dependent_lines":28,"n_total_lines":1208,"dependency_fraction":0.023178807947019868},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SIPA1","total_profiled":1310},"omim":[{"mim_id":"617504","title":"SIPA1-LIKE PROTEIN 1; SIPA1L1","url":"https://www.omim.org/entry/617504"},{"mim_id":"616851","title":"CATARACT 45; CTRCT45","url":"https://www.omim.org/entry/616851"},{"mim_id":"616655","title":"SIPA1-LIKE PROTEIN 3; SIPA1L3","url":"https://www.omim.org/entry/616655"},{"mim_id":"611609","title":"SIPA1-LIKE PROTEIN 2; SIPA1L2","url":"https://www.omim.org/entry/611609"},{"mim_id":"607785","title":"JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML","url":"https://www.omim.org/entry/607785"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoli","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":90.4}],"url":"https://www.proteinatlas.org/search/SIPA1"},"hgnc":{"alias_symbol":["SPA1"],"prev_symbol":[]},"alphafold":{"accession":"Q96FS4","domains":[{"cath_id":"3.30.1120.160","chopping":"213-326_525-551","consensus_level":"medium","plddt":89.6226,"start":213,"end":551},{"cath_id":"3.40.50.11210","chopping":"331-518","consensus_level":"medium","plddt":94.7219,"start":331,"end":518},{"cath_id":"2.30.29.30","chopping":"580-594_603-682","consensus_level":"medium","plddt":89.1198,"start":580,"end":682},{"cath_id":"2.30.42.10","chopping":"685-777","consensus_level":"medium","plddt":89.1253,"start":685,"end":777}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96FS4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96FS4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96FS4-F1-predicted_aligned_error_v6.png","plddt_mean":71.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SIPA1","jax_strain_url":"https://www.jax.org/strain/search?query=SIPA1"},"sequence":{"accession":"Q96FS4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96FS4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96FS4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96FS4"}},"corpus_meta":[{"pmid":"12827204","id":"PMC_12827204","title":"LAF1 ubiquitination by COP1 controls photomorphogenesis and is stimulated by SPA1.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12827204","citation_count":381,"is_preprint":false},{"pmid":"14597662","id":"PMC_14597662","title":"The COP1-SPA1 interaction defines a critical step in phytochrome A-mediated regulation of HY5 activity.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/14597662","citation_count":365,"is_preprint":false},{"pmid":"10205059","id":"PMC_10205059","title":"SPA1, a WD-repeat protein specific to phytochrome A signal transduction.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10205059","citation_count":215,"is_preprint":false},{"pmid":"10373454","id":"PMC_10373454","title":"Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10373454","citation_count":147,"is_preprint":false},{"pmid":"9477570","id":"PMC_9477570","title":"SPA1: a new genetic locus involved in phytochrome A-specific signal transduction.","date":"1998","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/9477570","citation_count":142,"is_preprint":false},{"pmid":"16142231","id":"PMC_16142231","title":"Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.","date":"2005","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16142231","citation_count":136,"is_preprint":false},{"pmid":"15065867","id":"PMC_15065867","title":"Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation.","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15065867","citation_count":86,"is_preprint":false},{"pmid":"15894557","id":"PMC_15894557","title":"Differences in the translation efficiency and mRNA stability mediated by 5'-UTR splice variants of human SP-A1 and SP-A2 genes.","date":"2005","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15894557","citation_count":85,"is_preprint":false},{"pmid":"12887588","id":"PMC_12887588","title":"The SPA1-like proteins SPA3 and SPA4 repress photomorphogenesis in the light.","date":"2003","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12887588","citation_count":83,"is_preprint":false},{"pmid":"12590145","id":"PMC_12590145","title":"AF-6 controls integrin-mediated cell adhesion by regulating Rap1 activation through the specific recruitment of Rap1GTP and SPA-1.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12590145","citation_count":82,"is_preprint":false},{"pmid":"15196935","id":"PMC_15196935","title":"Aquaporin-2 trafficking is regulated by PDZ-domain containing protein SPA-1.","date":"2004","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15196935","citation_count":78,"is_preprint":false},{"pmid":"15377498","id":"PMC_15377498","title":"SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages.","date":"2004","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15377498","citation_count":76,"is_preprint":false},{"pmid":"8179013","id":"PMC_8179013","title":"Human SP-A1 and SP-A2 genes are differentially regulated during development and by cAMP and glucocorticoids.","date":"1994","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8179013","citation_count":71,"is_preprint":false},{"pmid":"19392648","id":"PMC_19392648","title":"Genetic complexity of the human innate host defense molecules, surfactant protein A1 (SP-A1) and SP-A2--impact on function.","date":"2009","source":"Critical reviews in eukaryotic gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/19392648","citation_count":70,"is_preprint":false},{"pmid":"17220308","id":"PMC_17220308","title":"Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants.","date":"2007","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/17220308","citation_count":66,"is_preprint":false},{"pmid":"8179012","id":"PMC_8179012","title":"Characterization of mRNA transcripts and organization of human SP-A1 and SP-A2 genes.","date":"1994","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8179012","citation_count":65,"is_preprint":false},{"pmid":"20048345","id":"PMC_20048345","title":"Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1 and SP-A2: formation of tubular myelin in vivo requires both gene products.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20048345","citation_count":64,"is_preprint":false},{"pmid":"15456879","id":"PMC_15456879","title":"Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15456879","citation_count":63,"is_preprint":false},{"pmid":"3044610","id":"PMC_3044610","title":"SPA1: a gene important for chromosome segregation and other mitotic functions in S. cerevisiae.","date":"1988","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/3044610","citation_count":60,"is_preprint":false},{"pmid":"17189324","id":"PMC_17189324","title":"Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health.","date":"2006","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17189324","citation_count":57,"is_preprint":false},{"pmid":"9486201","id":"PMC_9486201","title":"Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin.","date":"1998","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9486201","citation_count":50,"is_preprint":false},{"pmid":"9689918","id":"PMC_9689918","title":"Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9689918","citation_count":47,"is_preprint":false},{"pmid":"27508436","id":"PMC_27508436","title":"Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films.","date":"2016","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27508436","citation_count":44,"is_preprint":false},{"pmid":"17542781","id":"PMC_17542781","title":"Structural and functional differences among human surfactant proteins SP-A1, SP-A2 and co-expressed SP-A1/SP-A2: role of supratrimeric oligomerization.","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17542781","citation_count":44,"is_preprint":false},{"pmid":"24704834","id":"PMC_24704834","title":"Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24704834","citation_count":39,"is_preprint":false},{"pmid":"12505869","id":"PMC_12505869","title":"Recombinant human SP-A1 and SP-A2 proteins have different carbohydrate-binding characteristics.","date":"2002","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12505869","citation_count":39,"is_preprint":false},{"pmid":"15310461","id":"PMC_15310461","title":"Rap1 and SPA-1 in hematologic malignancy.","date":"2004","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15310461","citation_count":38,"is_preprint":false},{"pmid":"34484180","id":"PMC_34484180","title":"Human Surfactant Protein SP-A1 and SP-A2 Variants Differentially Affect the Alveolar Microenvironment, Surfactant Structure, Regulation and Function of the Alveolar Macrophage, and Animal and Human Survival Under Various Conditions.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34484180","citation_count":35,"is_preprint":false},{"pmid":"21251160","id":"PMC_21251160","title":"SPA-1 controls the invasion and metastasis of human prostate cancer.","date":"2011","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/21251160","citation_count":35,"is_preprint":false},{"pmid":"11552738","id":"PMC_11552738","title":"Both human SP-A1 and Sp-A2 genes are expressed in small and large intestine.","date":"2001","source":"Pediatric pathology & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11552738","citation_count":34,"is_preprint":false},{"pmid":"29514790","id":"PMC_29514790","title":"Sipa1 deficiency-induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm.","date":"2018","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/29514790","citation_count":33,"is_preprint":false},{"pmid":"17678872","id":"PMC_17678872","title":"Differential effects of human SP-A1 and SP-A2 variants on phospholipid monolayers containing surfactant protein B.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17678872","citation_count":33,"is_preprint":false},{"pmid":"23069847","id":"PMC_23069847","title":"Genetic complexity of the human surfactant-associated proteins SP-A1 and SP-A2.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23069847","citation_count":32,"is_preprint":false},{"pmid":"12476938","id":"PMC_12476938","title":"Association of polymorphisms in the collagen region of human SP-A1 and SP-A2 genes with pulmonary tuberculosis in Indian population.","date":"2002","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12476938","citation_count":32,"is_preprint":false},{"pmid":"24729982","id":"PMC_24729982","title":"Differences in the alveolar macrophage proteome in transgenic mice expressing human SP-A1 and SP-A2.","date":"2013","source":"Journal of proteomics and genomics research","url":"https://pubmed.ncbi.nlm.nih.gov/24729982","citation_count":29,"is_preprint":false},{"pmid":"19037996","id":"PMC_19037996","title":"Spa-1 (Sipa1) and Rap signaling in leukemia and cancer metastasis.","date":"2008","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/19037996","citation_count":28,"is_preprint":false},{"pmid":"28237246","id":"PMC_28237246","title":"SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28237246","citation_count":27,"is_preprint":false},{"pmid":"19906411","id":"PMC_19906411","title":"Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.","date":"2009","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19906411","citation_count":27,"is_preprint":false},{"pmid":"22990111","id":"PMC_22990111","title":"Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells.","date":"2012","source":"Cancer genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/22990111","citation_count":26,"is_preprint":false},{"pmid":"17520282","id":"PMC_17520282","title":"Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells.","date":"2007","source":"Medical microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17520282","citation_count":26,"is_preprint":false},{"pmid":"20041285","id":"PMC_20041285","title":"SPA1 and DET1 act together to control photomorphogenesis throughout plant development.","date":"2009","source":"Planta","url":"https://pubmed.ncbi.nlm.nih.gov/20041285","citation_count":25,"is_preprint":false},{"pmid":"21601013","id":"PMC_21601013","title":"SP-A1, SP-A2 and SP-D gene polymorphisms in severe acute respiratory syncytial infection in Chilean infants.","date":"2011","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21601013","citation_count":24,"is_preprint":false},{"pmid":"9843844","id":"PMC_9843844","title":"Differential regulation of baboon SP-A1 and SP-A2 genes: structural and functional analysis of 5'-flanking DNA.","date":"1998","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9843844","citation_count":21,"is_preprint":false},{"pmid":"10229660","id":"PMC_10229660","title":"Glucocorticoid inhibition of human SP-A1 promoter activity in NCI-H441 cells.","date":"1999","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10229660","citation_count":21,"is_preprint":false},{"pmid":"17047059","id":"PMC_17047059","title":"Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17047059","citation_count":20,"is_preprint":false},{"pmid":"19089925","id":"PMC_19089925","title":"Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.","date":"2009","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19089925","citation_count":19,"is_preprint":false},{"pmid":"35096814","id":"PMC_35096814","title":"SIPA1 Enhances Aerobic Glycolysis Through HIF-2α Pathway to Promote Breast Cancer Metastasis.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35096814","citation_count":18,"is_preprint":false},{"pmid":"30972061","id":"PMC_30972061","title":"Differential Effects of Human SP-A1 and SP-A2 on the BAL Proteome and Signaling Pathways in Response to Klebsiella pneumoniae and Ozone Exposure.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30972061","citation_count":18,"is_preprint":false},{"pmid":"31354704","id":"PMC_31354704","title":"Major Effect of Oxidative Stress on the Male, but Not Female, SP-A1 Type II Cell miRNome.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31354704","citation_count":18,"is_preprint":false},{"pmid":"11457980","id":"PMC_11457980","title":"Light-induced growth promotion by SPA1 counteracts phytochrome-mediated growth inhibition during de-etiolation.","date":"2001","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11457980","citation_count":16,"is_preprint":false},{"pmid":"12753670","id":"PMC_12753670","title":"A single round PCR method for genotyping human surfactant protein (SP)-A1, SP-A2 and SP-D gene alleles.","date":"2003","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/12753670","citation_count":16,"is_preprint":false},{"pmid":"20693318","id":"PMC_20693318","title":"Human SP-A1 (SFTPA1) variant-specific 3' UTRs and poly(A) tail differentially affect the in vitro translation of a reporter gene.","date":"2010","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20693318","citation_count":16,"is_preprint":false},{"pmid":"19765277","id":"PMC_19765277","title":"Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.","date":"2009","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19765277","citation_count":15,"is_preprint":false},{"pmid":"9027487","id":"PMC_9027487","title":"Mitogen-inducible SIPA1 is mapped to the conserved syntenic groups of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9027487","citation_count":15,"is_preprint":false},{"pmid":"23661532","id":"PMC_23661532","title":"Sipa1 promoter polymorphism predicts risk and metastasis of lung cancer in Chinese.","date":"2013","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23661532","citation_count":14,"is_preprint":false},{"pmid":"15081616","id":"PMC_15081616","title":"Specific recruitment of SPA-1 to the immunological synapse: involvement of actin-bundling protein actinin.","date":"2004","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/15081616","citation_count":14,"is_preprint":false},{"pmid":"35453742","id":"PMC_35453742","title":"Extracellular Vesicles Derived from SIPA1high Breast Cancer Cells Enhance Macrophage Infiltration and Cancer Metastasis through Myosin-9.","date":"2022","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/35453742","citation_count":13,"is_preprint":false},{"pmid":"18033671","id":"PMC_18033671","title":"Spa-1 regulates the maintenance and differentiation of human embryonic stem cells.","date":"2008","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18033671","citation_count":13,"is_preprint":false},{"pmid":"32854247","id":"PMC_32854247","title":"The Importance of Redox Status in the Frame of Lifestyle Approaches and the Genetics of the Lung Innate Immune Molecules, SP-A1 and SP-A2, on Differential Outcomes of COVID-19 Infection.","date":"2020","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/32854247","citation_count":13,"is_preprint":false},{"pmid":"10914330","id":"PMC_10914330","title":"Induction of AP-1 binding to intron 1 of SP-A1 and SP-A2 is implicated in the phorbol ester inhibition of human SP-A promoter activity.","date":"2000","source":"Experimental lung research","url":"https://pubmed.ncbi.nlm.nih.gov/10914330","citation_count":13,"is_preprint":false},{"pmid":"33296812","id":"PMC_33296812","title":"SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells.","date":"2020","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33296812","citation_count":12,"is_preprint":false},{"pmid":"32193333","id":"PMC_32193333","title":"5-Aza-2'-deoxycytidine advances the epithelial-mesenchymal transition of breast cancer cells by demethylating Sipa1 promoter-proximal elements.","date":"2020","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/32193333","citation_count":12,"is_preprint":false},{"pmid":"34251043","id":"PMC_34251043","title":"Functional comparison of the WD-repeat domains of SPA1 and COP1 in suppression of photomorphogenesis.","date":"2021","source":"Plant, cell & environment","url":"https://pubmed.ncbi.nlm.nih.gov/34251043","citation_count":12,"is_preprint":false},{"pmid":"33753200","id":"PMC_33753200","title":"A novel nuclear localization region in SIPA1 determines protein nuclear distribution and epirubicin-sensitivity of breast cancer cells.","date":"2021","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33753200","citation_count":10,"is_preprint":false},{"pmid":"23771732","id":"PMC_23771732","title":"Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival.","date":"2013","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/23771732","citation_count":10,"is_preprint":false},{"pmid":"29500416","id":"PMC_29500416","title":"Sipa1 deficiency unleashes a host-immune mechanism eradicating chronic myelogenous leukemia-initiating cells.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29500416","citation_count":9,"is_preprint":false},{"pmid":"23358895","id":"PMC_23358895","title":"Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.","date":"2013","source":"Frontiers of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23358895","citation_count":9,"is_preprint":false},{"pmid":"36230738","id":"PMC_36230738","title":"SIPA1 Regulates LINC01615 to Promote Metastasis in Triple-Negative Breast Cancer.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36230738","citation_count":8,"is_preprint":false},{"pmid":"26901824","id":"PMC_26901824","title":"The contribution of SIPA1 and RRP1B germline polymorphisms to breast cancer phenotype, lymph node status and survival in a group of Lithuanian young breast cancer patients.","date":"2016","source":"Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/26901824","citation_count":7,"is_preprint":false},{"pmid":"33917539","id":"PMC_33917539","title":"SIPA1 Is a Modulator of HGF/MET Induced Tumour Metastasis via the Regulation of Tight Junction-Based Cell to Cell Barrier Function.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33917539","citation_count":7,"is_preprint":false},{"pmid":"32789016","id":"PMC_32789016","title":"The role of SIPA1 in the development of cancer and metastases (Review).","date":"2020","source":"Molecular and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32789016","citation_count":6,"is_preprint":false},{"pmid":"33141765","id":"PMC_33141765","title":"Differences in the alveolar macrophage toponome in humanized SP-A1 and SP-A2 transgenic mice.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/33141765","citation_count":6,"is_preprint":false},{"pmid":"18813851","id":"PMC_18813851","title":"Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1.","date":"2008","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18813851","citation_count":6,"is_preprint":false},{"pmid":"32082572","id":"PMC_32082572","title":"Using toponomics to characterize phenotypic diversity in alveolar macrophages from male mice treated with exogenous SP-A1.","date":"2020","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/32082572","citation_count":5,"is_preprint":false},{"pmid":"37500797","id":"PMC_37500797","title":"A novel transcription factor SIPA1: identification and verification in triple-negative breast cancer.","date":"2023","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/37500797","citation_count":4,"is_preprint":false},{"pmid":"37545505","id":"PMC_37545505","title":"The critical role of Rap1-GAPs Rasa3 and Sipa1 in T cells for pulmonary transit and egress from the lymph nodes.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37545505","citation_count":4,"is_preprint":false},{"pmid":"26889242","id":"PMC_26889242","title":"Suppression of SIPA-1 expression may reduce bladder cancer invasion and metastasis via the downregulation of E-cadherin and ZO-1.","date":"2015","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26889242","citation_count":4,"is_preprint":false},{"pmid":"40567222","id":"PMC_40567222","title":"Sipa1 Drives a Maladaptive Fibroblast-Myeloid Axis After Myocardial Infarction.","date":"2025","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/40567222","citation_count":3,"is_preprint":false},{"pmid":"24006220","id":"PMC_24006220","title":"The association of SIPA1 gene polymorphisms with breast cancer risk: evidence from published studies.","date":"2013","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24006220","citation_count":3,"is_preprint":false},{"pmid":"32257981","id":"PMC_32257981","title":"Study on the Relationship Between Respiratory Distress Syndrome and SP-A1 (rs1059057) Gene Polymorphism in Mongolian Very Premature Infants.","date":"2020","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32257981","citation_count":3,"is_preprint":false},{"pmid":"35431649","id":"PMC_35431649","title":"SIPA1 boosts migration and proliferation, and blocks apoptosis of glioma by activating the phosphorylation of the FAK signaling pathway.","date":"2022","source":"Journal of medical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35431649","citation_count":2,"is_preprint":false},{"pmid":"25673195","id":"PMC_25673195","title":"High SIPA-1 expression in proximal tubules of human kidneys under pathological conditions.","date":"2015","source":"Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban","url":"https://pubmed.ncbi.nlm.nih.gov/25673195","citation_count":2,"is_preprint":false},{"pmid":"35322074","id":"PMC_35322074","title":"The alveolar macrophage toponome of female SP-A knockout mice differs from that of males before and after SP-A1 rescue.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35322074","citation_count":2,"is_preprint":false},{"pmid":"41412211","id":"PMC_41412211","title":"A TRIM21-UCHL3-ITCH-SIPA1 axis promotes colorectal cancer growth and metastasis.","date":"2025","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/41412211","citation_count":1,"is_preprint":false},{"pmid":"39130435","id":"PMC_39130435","title":"SIPA1 promotes epithelial-mesenchymal transition in colorectal cancer through STAT3 activation.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/39130435","citation_count":1,"is_preprint":false},{"pmid":"38312659","id":"PMC_38312659","title":"SIPA1 promotes angiogenesis by regulating VEGF secretion in Müller cells through STAT3 activation.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38312659","citation_count":1,"is_preprint":false},{"pmid":"39488268","id":"PMC_39488268","title":"DDIT4 promotes erythroid differentiation and coordinates with SIPA1 to regulate erythroid proliferation in bone marrow of high altitude erythrocytosis.","date":"2024","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39488268","citation_count":1,"is_preprint":false},{"pmid":"9022283","id":"PMC_9022283","title":"Overexpression and functional analysis of a mitogen-inducible nuclear GTPase activating protein, Spa-1.","date":"1996","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9022283","citation_count":1,"is_preprint":false},{"pmid":"9183624","id":"PMC_9183624","title":"[Regulatory mechanisms of lymphocyte proliferation: roles of Spa-1 gene].","date":"1996","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/9183624","citation_count":1,"is_preprint":false},{"pmid":"9651531","id":"PMC_9651531","title":"Genomic organization and cloning of the human homologue of murine Sipa-1.","date":"1998","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9651531","citation_count":1,"is_preprint":false},{"pmid":"38594537","id":"PMC_38594537","title":"Characterization of PIF4 Phosphorylation by SPA1.","date":"2024","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/38594537","citation_count":0,"is_preprint":false},{"pmid":"40692252","id":"PMC_40692252","title":"[Expression of SIPA1 in colorectal cancer and its impact on its biological behavior].","date":"2025","source":"Zhonghua zhong liu za zhi [Chinese journal of oncology]","url":"https://pubmed.ncbi.nlm.nih.gov/40692252","citation_count":0,"is_preprint":false},{"pmid":"10894943","id":"PMC_10894943","title":"Genomic sequencing reveals the structure of the Kcnk6 and map3k11 genes and their close vicinity to the sipa1 gene on mouse chromosome 19.","date":"2000","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10894943","citation_count":0,"is_preprint":false},{"pmid":"41828652","id":"PMC_41828652","title":"Involvement of the Light Signalling Components HY5 and BIC1,2 and SPA1 in Plant Responses to Elevated Daytime UV-B Doses.","date":"2026","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41828652","citation_count":0,"is_preprint":false},{"pmid":"36277150","id":"PMC_36277150","title":"Erratum: [Corrigendum] Suppression of SIPA‑1 expression may reduce bladder cancer invasion and metastasis via the downregulation of E‑cadherin and ZO‑1.","date":"2022","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36277150","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47169,"output_tokens":7096,"usd":0.123974,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16312,"output_tokens":5874,"usd":0.114205,"stage2_stop_reason":"end_turn"},"total_usd":0.238179,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"SIPA1 (Spa-1) N-terminal fragment (amino acids 10-183) is sufficient for Rap GAP activity; Spa-1 preferentially stimulates Rsr1 GTPase rather than Rap1 GTPase, distinguishing it from GAP3m which prefers Rap1.\",\n      \"method\": \"In vitro GTPase stimulatory assay using GST-fusion protein expressed in E. coli; mutational analysis of N-terminal fragment\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with mutagenesis, single lab, single study\",\n      \"pmids\": [\"9022283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SIPA1 (SPA-1) acts as a Rap1 GAP that negatively regulates Rap1 activation; overexpression in HeLa cells induces cell rounding and reduced adhesion to fibronectin-coated dishes, while suppression of Rap1 activation inhibits cell adhesion induced by extracellular matrix and soluble factors.\",\n      \"method\": \"Transfection of SPA-1 in 293T and HeLa cells; tetracycline-inducible overexpression system; retroviral overexpression in 32D cells; cell adhesion assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean gain-of-function with defined cellular phenotype, multiple cell types, single lab\",\n      \"pmids\": [\"10373454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SPA-1 binds to the PDZ domain of the cytoskeleton-anchoring protein AF-6 via a probable internal PDZ ligand motif within its GAP-related domain. AF-6 recruits both SPA-1 and Rap1GTP to cell attachment sites, and co-expression of AF-6 inhibits Rap1GTP levels and β1 integrin-mediated cell adhesion to fibronectin in SPA-1-expressing conditions.\",\n      \"method\": \"Co-immunoprecipitation in 293T cells and thymocytes; in vitro binding studies with truncated fragments and mutants; immunostaining; tetracycline-inducible HeLa cell adhesion assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP in native and transfected cells, in vitro binding with mutants, functional adhesion assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12590145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Bromodomain protein Brd4 interacts with SIPA1 in the nucleus of living cells; Brd4 enhances the Rap GAP activity of SIPA1. Ectopic expression of either protein alone disrupts normal cell cycle progression, but co-expression of both restores it, indicating a functional balance is required for proper cell division.\",\n      \"method\": \"Immunopurification and mass spectrometry; bimolecular fluorescence complementation in living cells; GAP activity assay; cell cycle analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — MS-based interaction identification, bimolecular fluorescence complementation, in vitro GAP activity assay, functional cell cycle readout, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"15456879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SIPA1 (SPA-1) directly binds to aquaporin-2 (AQP2) via its PDZ domain, co-localizes with AQP2 in renal collecting ducts, and regulates AQP2 trafficking to the apical membrane. A SIPA1 mutant lacking Rap1GAP activity and constitutively active Rap1V12 inhibit AQP2 trafficking; AQP2 trafficking is impaired in SIPA1-deficient mice.\",\n      \"method\": \"Biochemical pulldown/Co-immunoprecipitation; immunolocalization; functional trafficking assay with GAP-dead mutant and Rap1V12; SIPA1 knockout mice\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, loss-of-function in vivo (KO mice), dominant-negative and constitutively active mutants, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"15196935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SIPA1 is specifically recruited to the immunological synapse upon T cell antigen recognition, co-localizing with actin and alpha-actinin. SIPA1 interacts with the actin-bundling protein alpha-actinin (identified by yeast two-hybrid), suggesting it restrains Rap1GTP levels at the local TCR-signaling complex.\",\n      \"method\": \"Anti-SPA-1 antibody immunostaining and GFP-SPA-1 live imaging; yeast two-hybrid interaction screen; immunostaining co-localization at immunological synapse\",\n      \"journal\": \"Immunology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — localization by imaging tied to functional context, yeast two-hybrid interaction without in vitro validation, single lab\",\n      \"pmids\": [\"15081616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A nonsynonymous amino acid polymorphism in Sipa1 affects its Rap-GAP function; ectopic Sipa1 expression increases spontaneous metastasis while knockdown reduces it, demonstrating that Sipa1 levels correlate with and functionally regulate metastatic capacity.\",\n      \"method\": \"Spontaneous metastasis assays in mice; ectopic expression and shRNA knockdown; biochemical Rap-GAP activity assessment of polymorphic variants\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain- and loss-of-function in vivo metastasis assays with defined molecular mechanism (Rap-GAP activity), replicated across expression and knockdown approaches, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16142231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In SPA-1-deficient mice, BCR-ABL+ hematopoietic progenitor cells (HPCs) sustain higher levels of Lin-c-Kit+ leukemic progenitors than wild-type HPCs and can serially transfer CML. BCR-ABL causes partial downregulation of endogenous SPA-1 expression, and endogenous SPA-1 normally limits expansion/survival of BCR-ABL+ leukemic progenitors.\",\n      \"method\": \"CML mouse model with BCR-ABL-transduced wild-type and SPA-1-deficient HPCs; serial transplantation experiments; flow cytometry; RT-PCR for SPA-1 expression\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function, serial transplantation, multiple cellular phenotypic readouts, defined mechanistic pathway, single lab\",\n      \"pmids\": [\"17047059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BCR-ABL P190 forms a protein-protein complex with SPA-1 in COS-1 cells and primary lymphoblastic leukemia cells. The interaction did not affect P190 tyrosine kinase activity or SPA-1 tyrosine phosphorylation, but P190 and SPA-1 co-localized to peripheral actin structures and SPA-1 expression decreased migration of leukemic lymphoblasts.\",\n      \"method\": \"Co-immunoprecipitation in COS-1 cells and primary P190 BCR/ABL transgenic mouse lymphoblasts; tyrosine kinase assay; immunofluorescence co-localization; migration assay\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — reciprocal Co-IP in native cells, functional migration assay, but interaction mechanism not fully resolved, single lab\",\n      \"pmids\": [\"18813851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In human embryonic stem cells (hESCs), Spa-1 is expressed and maintains self-renewal; RNAi-mediated Spa-1 knockdown causes hESCs to differentiate into three germ layers even under undifferentiated conditions. This effect is mediated via Rap1/Raf/MEK/ERK signaling.\",\n      \"method\": \"RNA interference (pSUPER.retro.puro vector) in hESCs; immunocytochemistry for pluripotency markers; Western blot for signaling pathway components\",\n      \"journal\": \"The International journal of developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean loss-of-function with defined cellular phenotype and pathway identification, single lab, single method\",\n      \"pmids\": [\"18033671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SPA-1 expression in human prostate cancer cells (LNCaP) promotes lymph node metastasis without affecting primary tumor size. SPA-1 attenuates ECM-mediated Rap1 activation, reduces adhesion to collagens and fibronectin. SPA-1 also decreases nuclear Brd4 levels, reducing expression of ECM-related genes. Dominant-active Rap1V12 or shRNA knockdown of SIPA1 suppresses metastasis.\",\n      \"method\": \"SIPA1 transduction in LNCaP; shRNA knockdown in PC3; in vivo metastasis assay in SCID mice; Rap1 activation assay; immunoblot for Brd4 and ECM-related proteins; cell adhesion assays\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function in vivo, multiple molecular readouts including Rap1 activation and Brd4 redistribution, single lab with several orthogonal methods\",\n      \"pmids\": [\"21251160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SIPA1 is primarily localized to the nucleus in highly invasive breast cancer cells (MDA-MB-231). Nuclear SIPA1 directly interacts with the integrin β1 promoter and activates its transcription, promoting cell adhesion and invasion. SIPA1 knockdown reduces FAK and Akt phosphorylation and MMP9 expression downstream of integrin β1.\",\n      \"method\": \"Subcellular fractionation; chromatin immunoprecipitation (ChIP) / promoter interaction assay; SIPA1 knockdown by siRNA; Western blot for FAK, Akt, MMP9; invasion and adhesion assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct promoter binding, loss-of-function with multiple downstream pathway readouts, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"24704834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Sipa1 deficiency in mice causes phenotypic and functional alterations of BM mesenchymal stem and progenitor cells prior to initiation of myeloproliferative neoplasm (MPN), with dysregulation of Dicer1, Kitl, Angptl1, Cxcl12, and Thpo. The altered Sipa1-/- BM niche is sufficient to drive MDS/MPN upon transplantation of normal hematopoietic cells.\",\n      \"method\": \"Sipa1 knockout mouse model; bone marrow transplantation; flow cytometry; RNA sequencing of BM stromal cells\",\n      \"journal\": \"Blood advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function, transplantation experiment establishing niche sufficiency, transcriptomic pathway identification, single lab\",\n      \"pmids\": [\"29514790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Sipa1-/- mesenchymal stromal cells (MSCs) show enhanced activation and directed migration toward Bcr-Abl+ cells, preferentially produce Cxcl9, which recruits Sipa1-/- memory T cells with augmented chemotactic activity, thereby eradicating Bcr-Abl+ hematopoietic progenitors. The resistance to CML requires both T cells and nonhematopoietic cells.\",\n      \"method\": \"Sipa1 knockout mouse model; bone marrow transplantation; T cell depletion experiments; cytokine measurement; cell migration assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout, transplantation, cellular depletion, mechanistic pathway (Cxcl9/T cell recruitment) identified, multiple orthogonal approaches\",\n      \"pmids\": [\"29500416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SIPA1 promotes transcription of EPAS1 (HIF-2α) and upregulates multiple glycolysis-related genes, shifting ATP production from oxidative phosphorylation to aerobic glycolysis. Knockdown of SIPA1 suppresses tumor metastasis in vitro and in vivo.\",\n      \"method\": \"SIPA1 overexpression and knockdown in breast cancer cells; metabolic flux assays; qRT-PCR for HIF-2α and glycolysis genes; in vivo metastasis assay\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function, metabolic and gene expression readouts, in vivo validation, single lab\",\n      \"pmids\": [\"35096814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SIPA1 promotes stemness features of breast cancer cells by increasing SMAD2 and SMAD3 expression, leading to upregulation of stemness transcription factors. Blocking SMAD3 phosphorylation with the inhibitor SIS3 abolishes SIPA1-induced stemness and restores chemotherapy sensitivity.\",\n      \"method\": \"SIPA1 overexpression and knockdown; tumorsphere formation assay; Western blot for SMAD2/3; pharmacological SMAD3 inhibition; chemotherapy sensitivity assays in vitro and in vivo\",\n      \"journal\": \"Stem cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with pharmacological validation, multiple cellular readouts, single lab\",\n      \"pmids\": [\"33296812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Methylation of the CpG island in the Sipa1 promoter-proximal elements inversely correlates with SIPA1 protein expression in breast cancer cells. Demethylation by 5-Aza-CdR increases SIPA1 expression and promotes EMT; SIPA1 knockdown reverses EMT in MDA-MB-231 cells while SIPA1 overexpression promotes EMT in MCF7 cells.\",\n      \"method\": \"Bisulfite sequencing; 5-Aza-CdR treatment; SIPA1 overexpression and knockdown; Western blot for EMT markers\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — epigenetic regulation established by bisulfite sequencing and pharmacological demethylation with functional EMT readout, gain- and loss-of-function, single lab\",\n      \"pmids\": [\"32193333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A novel nuclear localization region (NLR, residues 140-179) of SIPA1 containing His160 is required for nuclear import; deletion of NLR prevents nuclear localization, abolishes SIPA1-dependent cell migration promotion and upregulation of ABCB1/MDR1, and eliminates SIPA1-promoted epirubicin resistance in breast cancer cells.\",\n      \"method\": \"Deletion mutagenesis; subcellular localization by imaging; Western blot for MDR1; cell migration and proliferation assays; drug sensitivity assay\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis with functional consequence on localization and multiple phenotypic readouts, single lab\",\n      \"pmids\": [\"33753200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SIPA1 promotes tight junction-based barrier function and cancer metastasis in lung cancer by maintaining MET protein levels (not transcript) through regulation of Grb2, SOCS, and PKCμ, which control MET internalization and recycling. SIPA1 knockdown impairs MET-dependent barrier function and reduces invasion.\",\n      \"method\": \"SIPA1 knockdown in lung cancer cell lines; Western blot for MET protein and transcript; barrier function assay; invasion assay; HGF/MET pathway analysis\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — loss-of-function with molecular pathway dissection, multiple readouts, single lab\",\n      \"pmids\": [\"33917539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SIPA1 promotes MYH9 (myosin-9) transcription in breast cancer cells, elevating myosin-9 in cancer-derived extracellular vesicles (EVs). These EVs enhance macrophage migration and tumor infiltration, and blocking myosin-9 suppresses macrophage infiltration.\",\n      \"method\": \"SIPA1 knockdown; EV isolation; Western blot for myosin-9 in cells and EVs; macrophage migration assay in vitro and in vivo; blebbistatin (myosin-9 inhibitor) treatment\",\n      \"journal\": \"Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — SIPA1 loss-of-function linking transcriptional regulation of MYH9 to EV-mediated macrophage recruitment, in vitro and in vivo validation, single lab\",\n      \"pmids\": [\"35453742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SIPA1 functions as a transcription factor, binding DNA via a defined DNA-binding region (DBR) that recognizes a TGAGTCAB motif (confirmed by EMSA). Importin β1 interacts with SIPA1 upon fibronectin treatment. SIPA1 directly regulates transcription of fibronectin 1 (FN1) in a DBR-dependent manner in vitro and in vivo, promoting TNBC cell migration and invasion.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA); Co-immunoprecipitation with Importin β1; ChIP; DBR deletion mutants; in vivo tumor xenograft; single-cell RNA sequencing of clinical specimens\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — EMSA demonstrating direct DNA binding, EMSA motif mapping, ChIP, deletion mutagenesis, and in vivo validation, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"37500797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Rasa3 and Sipa1 are critical Rap1-inactivating proteins in T cells controlling lymphocyte trafficking. Combined loss of Rasa3 and Sipa1 induces spontaneous Rap1 activation, causing T cell trapping in lung capillaries via LFA-1-dependent adhesion (rescued by LFA-1 antibody, talin1 loss, or Rap1 loss), and impairs T cell egress from lymph nodes despite normal entry and fast migration.\",\n      \"method\": \"Double knockout mouse model; LFA-1 antibody blockade; genetic epistasis (talin1 KO, Rap1 KO rescue); intravital imaging; flow cytometry\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with multiple rescue experiments (antibody, talin KO, Rap1 KO), in vivo phenotypic readouts, mechanistic pathway defined, single lab\",\n      \"pmids\": [\"37545505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIPA1 promotes EMT in colorectal cancer by activating STAT3 phosphorylation, which leads to STAT3 nuclear translocation. Pharmacological STAT3 inhibition (STTITA) in SIPA1-overexpressing cells reverses EMT marker changes, placing SIPA1 upstream of STAT3 in this pathway.\",\n      \"method\": \"SIPA1 knockdown and overexpression; STAT3 inhibitor co-treatment; Western blot for pSTAT3, EMT markers; proliferation and migration assays\",\n      \"journal\": \"Heliyon\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — gain- and loss-of-function with pharmacological epistasis for pathway placement, single lab\",\n      \"pmids\": [\"39130435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIPA1 activates STAT3 phosphorylation in Müller cells, leading to nuclear STAT3 translocation and upregulation of VEGF expression; SIPA1-dependent VEGF secretion promotes retinal vascular endothelial cell mobility. STAT3 inhibition (STATTIC) blocks SIPA1's effect on VEGF expression.\",\n      \"method\": \"SIPA1 overexpression in Müller cells; STAT3 inhibitor (STATTIC) co-treatment; Western blot for pSTAT3 and VEGF; endothelial cell mobility assay\",\n      \"journal\": \"Heliyon\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — gain-of-function with pharmacological epistasis, functional angiogenesis readout, single lab\",\n      \"pmids\": [\"38312659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UCHL3 deubiquitinase directly binds SIPA1 and removes K48-linked polyubiquitin chains from SIPA1 at lysine 805, protecting it from proteasomal degradation. The E3 ligase ITCH promotes K48-linked ubiquitination and degradation of SIPA1, acting antagonistically to UCHL3. TRIM21 targets UCHL3 for proteasomal degradation, thus regulating the UCHL3-ITCH-SIPA1 axis.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assays with K48-specific linkage analysis; site-directed mutagenesis (K805); proteasome inhibitor experiments; overexpression and knockdown in CRC cells\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro ubiquitination assay, site-specific mutagenesis identifying K805, identification of writer (ITCH), eraser (UCHL3), and upstream regulator (TRIM21), single lab with multiple orthogonal methods\",\n      \"pmids\": [\"41412211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Sipa1 in cardiac fibroblasts promotes production of CCL2, CCL7, and GM-CSF early after myocardial infarction via a noncanonical RasGRP2-Ras-JNK signaling pathway (independent of canonical Rap1 signaling), facilitating accumulation of Ly6C-high monocytes and CCR2+ macrophages and worsening post-MI cardiac outcomes. Cardiac fibroblast-specific Sipa1 conditional knockout prevents excessive inflammation and adverse remodeling.\",\n      \"method\": \"Sipa1 global knockout and cardiac fibroblast-specific conditional knockout mice; bone marrow transplantation; flow cytometry; transcriptomic analysis; cytokine measurement; pharmacological/genetic dissection of signaling (RasGRP2-Ras-JNK vs Rap1 pathway)\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO, bone marrow transplantation establishing cellular source, mechanistic pathway dissection showing noncanonical signaling, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"40567222\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SIPA1 is a mitogen-inducible Rap1 GTPase-activating protein (Rap-GAP) whose catalytic activity resides in its N-terminal domain; it negatively regulates Rap1-GTP levels in diverse cellular contexts including lymphocyte adhesion, T cell immunological synapse signaling, aquaporin-2 trafficking, hematopoietic stem cell homeostasis, and cancer metastasis. Beyond its cytoplasmic GAP function, nuclear SIPA1 acts as a transcription factor—binding a TGAGTCAB DNA motif via a defined DNA-binding region—to regulate integrin β1, fibronectin 1, EPAS1/HIF-2α, MYH9, and other targets promoting cancer cell invasion and metabolic reprogramming. Its activity is modulated by protein interactions (AF-6, Brd4, alpha-actinin, Importin β1, BCR-ABL) and by post-translational control: the deubiquitinase UCHL3 stabilizes SIPA1 by removing K48-linked ubiquitin at K805, while the E3 ligase ITCH promotes its degradation. In cardiac fibroblasts after myocardial infarction, SIPA1 drives a noncanonical RasGRP2-Ras-JNK pathway (independent of Rap1) to produce CCL2/CCL7/GM-CSF and promote maladaptive inflammation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SIPA1 is a Rap1 GTPase-activating protein whose catalytic activity resides in an N-terminal GAP domain (amino acids 10–183) and which negatively regulates Rap1-GTP levels across diverse contexts including cell adhesion, immune cell trafficking, hematopoietic homeostasis, and cancer metastasis [#0, #1, #6]. By restraining Rap1 activation, SIPA1 controls β1-integrin- and ECM-mediated adhesion: its overexpression rounds cells and reduces fibronectin adhesion, and the GAP function is required for normal aquaporin-2 trafficking in renal collecting ducts and for spatial control of Rap1-GTP at the T cell immunological synapse [#1, #4, #5]. In T cells, SIPA1 acts redundantly with Rasa3 to keep Rap1 inactive; combined loss triggers spontaneous, LFA-1/talin1-dependent adhesion and impaired lymph node egress [#21]. Its GAP activity is spatially organized and modulated by protein partners—AF-6 recruits SIPA1 and Rap1-GTP to attachment sites, alpha-actinin localizes it at the synapse, and nuclear Brd4 enhances its GAP activity to balance cell cycle progression [#2, #5, #3]. Beyond the cytoplasm, nuclear SIPA1 functions as a transcription factor that binds a TGAGTCAB motif through a defined DNA-binding region and a nuclear localization region (residues 140–179), directly activating transcription of integrin β1, fibronectin 1, EPAS1/HIF-2α, and MYH9 to drive cancer cell adhesion, invasion, glycolytic reprogramming, and macrophage recruitment [#20, #11, #17, #14, #19]. SIPA1 levels functionally determine metastatic capacity and are controlled epigenetically by promoter methylation and post-translationally by a UCHL3–ITCH ubiquitin axis, in which UCHL3 removes K48-linked ubiquitin at K805 to stabilize SIPA1 while ITCH promotes its degradation [#6, #16, #24]. In bone marrow, SIPA1 limits BCR-ABL+ leukemic progenitor expansion and shapes the mesenchymal niche, and in cardiac fibroblasts after myocardial infarction it drives a noncanonical RasGRP2–Ras–JNK pathway, independent of Rap1, to produce CCL2/CCL7/GM-CSF and promote maladaptive inflammation [#7, #12, #25].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that SIPA1 carries intrinsic GTPase-activating activity localized to its N-terminus, defining it as a catalytic GAP rather than a passive adaptor.\",\n      \"evidence\": \"In vitro GTPase stimulatory assay with GST-fusion N-terminal fragment and mutagenesis in E. coli\",\n      \"pmids\": [\"9022283\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Preference for Rsr1 over Rap1 in vitro left the physiological substrate ambiguous\", \"No cellular validation of substrate specificity\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed SIPA1 negatively regulates Rap1 in cells, linking its GAP activity to control of ECM-mediated adhesion.\",\n      \"evidence\": \"Inducible and retroviral overexpression with adhesion assays in 293T, HeLa, and 32D cells\",\n      \"pmids\": [\"10373454\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Gain-of-function only; endogenous loss-of-function not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined how SIPA1 GAP activity is spatially targeted, showing AF-6 recruits both SIPA1 and Rap1-GTP to attachment sites to control integrin adhesion.\",\n      \"evidence\": \"Reciprocal Co-IP in 293T cells and thymocytes, in vitro binding with mutants, inducible adhesion assays\",\n      \"pmids\": [\"12590145\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Internal PDZ-ligand motif only 'probable'\", \"Structural basis of recruitment unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Extended SIPA1's GAP function to physiological membrane trafficking and revealed a nuclear partner balancing its activity in the cell cycle.\",\n      \"evidence\": \"AQP2 pulldown, KO mouse trafficking assays, and Brd4 interaction by BiFC/MS with GAP and cell-cycle readouts\",\n      \"pmids\": [\"15196935\", \"15456879\", \"15081616\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism by which Brd4 enhances GAP activity not resolved\", \"alpha-actinin interaction (Y2H) lacks in vitro validation\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated SIPA1 dose- and polymorphism-dependently controls metastatic capacity, establishing it as a functional metastasis-efficiency gene.\",\n      \"evidence\": \"Spontaneous metastasis assays with ectopic expression and shRNA in mice, plus Rap-GAP assays of variants\",\n      \"pmids\": [\"16142231\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Whether metastatic effect is cytoplasmic GAP or nuclear function was not separated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Placed SIPA1 in the hematopoietic/leukemic context, showing it limits BCR-ABL+ progenitor expansion and physically complexes with BCR-ABL P190.\",\n      \"evidence\": \"BCR-ABL CML mouse model with serial transplantation; Co-IP in COS-1 and primary lymphoblasts with migration assays\",\n      \"pmids\": [\"17047059\", \"18813851\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Functional consequence of the SIPA1–P190 complex on kinase signaling not established\", \"Mechanism of SIPA1 downregulation by BCR-ABL unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Implicated SIPA1 in stem cell self-renewal via Rap1/Raf/MEK/ERK, broadening its role beyond adhesion.\",\n      \"evidence\": \"RNAi knockdown in human ESCs with pluripotency marker and signaling readouts\",\n      \"pmids\": [\"18033671\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single knockdown approach without rescue\", \"Direct link between SIPA1 GAP activity and ERK pathway not dissected\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected SIPA1 metastasis function to dual mechanisms—attenuating Rap1-mediated ECM adhesion and reducing nuclear Brd4 to lower ECM gene expression.\",\n      \"evidence\": \"Gain/loss-of-function in prostate cancer cells with in vivo metastasis, Rap1 activation, and Brd4 immunoblot\",\n      \"pmids\": [\"21251160\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"How SIPA1 alters nuclear Brd4 levels mechanistically unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified nuclear SIPA1 as a direct transcriptional activator, showing it binds the integrin β1 promoter to drive invasion signaling.\",\n      \"evidence\": \"Subcellular fractionation, ChIP/promoter binding, and siRNA knockdown with FAK/Akt/MMP9 readouts in MDA-MB-231 cells\",\n      \"pmids\": [\"24704834\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"DNA-binding motif and domain not yet defined at this stage\", \"Relationship between nuclear and GAP functions unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined a non-cell-autonomous role in the bone marrow niche, showing Sipa1-deficient stroma drives myeloid neoplasia yet also enables anti-CML immunity via Cxcl9/T-cell recruitment.\",\n      \"evidence\": \"Sipa1 KO mice, bone marrow transplantation, T-cell depletion, RNA-seq of stromal cells, migration/cytokine assays\",\n      \"pmids\": [\"29514790\", \"29500416\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct SIPA1 substrates/targets in MSCs not identified\", \"How niche dysregulation initiates MDS/MPN mechanistically unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Expanded the nuclear transcriptional program of SIPA1 to metabolic reprogramming, stemness, and EMT, and identified promoter methylation as an upstream control.\",\n      \"evidence\": \"Overexpression/knockdown in breast cancer cells with metabolic flux, SMAD2/3 and EMT readouts, bisulfite sequencing and demethylation\",\n      \"pmids\": [\"35096814\", \"33296812\", \"32193333\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct vs indirect transcriptional control of EPAS1/SMAD targets not all resolved\", \"Single-lab studies for each phenotype\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapped a nuclear localization region required for SIPA1's nuclear oncogenic functions and linked SIPA1 to MET-dependent barrier function in lung cancer.\",\n      \"evidence\": \"Deletion mutagenesis of NLR (140–179) with localization/drug-resistance readouts; SIPA1 knockdown with MET protein/transcript and barrier assays\",\n      \"pmids\": [\"33753200\", \"33917539\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Import receptor for the NLR not identified in this study\", \"Mechanism of SIPA1 control over MET internalization indirect\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked nuclear SIPA1 transcriptional activity to tumor immune microenvironment shaping through MYH9 and extracellular-vesicle-mediated macrophage recruitment.\",\n      \"evidence\": \"SIPA1 knockdown, EV isolation, myosin-9 immunoblot, macrophage migration in vitro/in vivo, blebbistatin treatment\",\n      \"pmids\": [\"35453742\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct ChIP evidence for MYH9 promoter binding not shown\", \"EV loading mechanism unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided direct biochemical proof that SIPA1 is a sequence-specific transcription factor, defining its TGAGTCAB-recognizing DNA-binding region, FN1 target, and Importin β1-dependent nuclear import.\",\n      \"evidence\": \"EMSA motif mapping, ChIP, DBR deletion mutants, Importin β1 Co-IP, in vivo xenograft and scRNA-seq\",\n      \"pmids\": [\"37500797\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Full genome-wide target repertoire not defined\", \"Structural basis of motif recognition unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established the in vivo redundancy of SIPA1 with Rasa3 as a Rap1 brake controlling lymphocyte trafficking and egress.\",\n      \"evidence\": \"Rasa3/Sipa1 double-KO mice with LFA-1 blockade, talin1 and Rap1 epistasis rescues, and intravital imaging\",\n      \"pmids\": [\"37545505\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Relative contribution of SIPA1 alone versus Rasa3 not separated\", \"Spatial regulation in T cells not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified STAT3 phosphorylation as a shared downstream effector through which SIPA1 drives EMT in colorectal cancer and VEGF-mediated angiogenesis in retinal Müller cells.\",\n      \"evidence\": \"Gain/loss-of-function with STAT3 inhibitor epistasis and pSTAT3/EMT/VEGF readouts\",\n      \"pmids\": [\"39130435\", \"38312659\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism by which SIPA1 activates STAT3 phosphorylation not defined\", \"Whether GAP or nuclear function drives STAT3 activation unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined the post-translational control of SIPA1 stability and a Rap1-independent signaling role, revealing a UCHL3–ITCH ubiquitin axis at K805 and a noncanonical RasGRP2–Ras–JNK inflammatory pathway in cardiac fibroblasts.\",\n      \"evidence\": \"K48-linkage ubiquitination assays with K805 mutagenesis and writer/eraser/regulator identification; cardiac-fibroblast-specific Sipa1 conditional KO with pathway dissection\",\n      \"pmids\": [\"41412211\", \"40567222\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"How SIPA1 engages RasGRP2-Ras-JNK independently of its GAP activity is unresolved\", \"Conditions selecting Rap1-dependent vs noncanonical signaling unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SIPA1's two distinct activities—cytoplasmic Rap1-GAP and nuclear sequence-specific transcription factor—are coordinated, partitioned, and switched within a cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No structural model coupling the GAP domain to DNA-binding function\", \"Signals that direct SIPA1 to nucleus vs cytoplasm only partly mapped (Importin β1, NLR)\", \"Genome-wide direct target set incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 6]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 4, 21]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [11, 20]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [11, 14, 19, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 11, 17, 20]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 2, 5]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [5, 8]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 9, 21]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 7, 10, 11]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [11, 14, 19, 20]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [13, 21, 25]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [2, 10, 11, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RAP1\", \"AFDN\", \"BRD4\", \"ACTN\", \"AQP2\", \"BCR-ABL\", \"KPNB1\", \"UCHL3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}